Three patients with spinal muscular atrophy had improved muscle strength and could walk farther after a month of daily spinal stimulation.

Three patients with spinal muscular atrophy had improved muscle strength and could walk farther after a month of daily spinal ...

SPINRAZA is an approved treatment for spinal muscular atrophy in over 71 countries ... vomiting and back pain. Laboratory tests can monitor for renal toxicity and coagulation abnormalities ...

NEW YORK – Dutch biotech firm MRC Holland said Wednesday that it has received CE marking under the EU's In Vitro Diagnostic Regulation for a molecular test that is used to screen newborns for spinal ...

But lawmakers largely did not act. On Monday, as Mr. Trump took the oath of office to begin his second term, he asserted a muscular vision of presidential power. He not only revived some of the ...

Talditercept alfa is under clinical development by Biohaven and currently in Phase III for Spinal Muscular Atrophy (SMA). According to GlobalData, Phase III drugs for Spinal Muscular Atrophy (SMA) ...

Lost spacecraft: SpaceX said Thursday that its Starship spacecraft — which was meant to lap Earth and splash down in the Indian Ocean — exploded not long after its 7th test flight took off ...

Among them is the “muscular baba” from Russia, who has grabbed the spotlight due to his well-defined physique. A “muscular baba” at Mahakumbh Mela 2025, who left social media in awe.

A doctor explained to reporters that a necessary procedure was performed to take out the knife lodged into the actor’s body, at the same time, addressed a “spinal fluid leak" caused by the injury. The ...

A pet owner who was curious about his rescue dog's mixed-breed heritage was left surprised at what a DNA test revealed. Max Matthai from Baltimore, Maryland, makes no bones about the fact he didn ...

Geographic atrophy (GA) can be visually confusing. People often tell me that one minute they see something, and the next minute they don’t. For example, the word you’re reading might be “she ...

If approved, subcutaneous autoinjector Leqembi will be the only Alzheimer's medication that can be administered at home. The FDA has set a goal date of Aug. 31, 2025. The FDA has accepted a biologics ...